L. Fregonese (London, United Kingdom), G. Vagheggini (Volterra (PI), Italy)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Multi-disciplinary approach to Long COVID in hospitalised and non-hospitalised COVID-19 patients (IMPACT-COVID study)
S. Johnsen (København, Denmark), S. Sattler (København, Denmark), K. Miskowiak (København, Denmark), K. Kunalan (København, Denmark), A. Victor (København, Denmark), L. Pedersen (København, Denmark), H. Frost Andreassen (København, Denmark), B. Jolanta Jørgensen (København, Denmark), H. Heebøll (København, Denmark), M. Brun Andersen (København, Denmark), L. Marner (København, Denmark), C. Hædersdal (København, Denmark), H. Hansen (København, Denmark), S. Ditlev (København, Denmark), C. Porsbjerg (København, Denmark), T. Lapperre (Antwerp, Belgium)
|    |
Post-COVID-19 Symptom Burden: What is Long-COVID and how should we manageit?
D. Sykes (Leeds, United Kingdom), L. Holdsworth (Leeds, United Kingdom), N. Jawad (Leeds, United Kingdom), P. Gunasekera (Leeds, United Kingdom), A. Morice (Leeds, United Kingdom), M. Crooks (Leeds, United Kingdom)
| |
Correlation of severity of the lung involvement in chest tomography with 6-minute walk test (6MWT) after hospital discharge in patients with COVID-19
B. Scharlack Vian (Campinas, Brazil), P. Maximink Esteves Villar (Campinas, Brazil), H. Alcântara Engleitner (Campinas, Brazil), C. Salem Tamesawa (Campinas, Brazil), M. Magalhães Morello (Campinas, Brazil), . Bacchin De Oliveira (Campinas, Brazil), A. Cavallaro Baraúna Lima (Campinas, Brazil), . Dugolin Ceccato (Campinas, Brazil), J. Furtado Silva (Campinas, Brazil), R. Macedo (Campinas, Brazil), L. Roceto Ratti (Campinas, Brazil), . Corso Pereira (Campinas, Brazil)
| |
Evaluation of COVID-19 radiological abnormalities at follow-up.
M. Syed (Stafford, United Kingdom), S. Morton (Stafford, United Kingdom), S. Bikmalla (Stoke-on-Trent (Staffordshire), United Kingdom)
| |
Consequences of SARS-COV-2 Pneumonia on Lung function
N. Orzes (Brescia, Italy), L. Pini (Brescia, Italy), G. Levi (Brescia, Italy), S. Uccelli (Brescia, Italy), F. Cettolo (Brescia, Italy), J. Giordani (Brescia, Italy), A. Pini (Paris, France), M. Guerini (Brescia, Italy), M. Ciarfaglia (Brescia, Italy), C. Tantucci (Brescia, Italy)
| |
CAT score as a predictor of long term complications of COVID-19
R. Aul (London, United Kingdom), A. Draper (London, United Kingdom), A. Dunleavy (London, United Kingdom), S. Ruickbie (London, United Kingdom), H. Meredith (London, United Kingdom), N. Walters (London, United Kingdom), J. Gates (London, United Kingdom), C. Van Zeller (London, United Kingdom), V. Taylor (London, United Kingdom), R. Dunwoody (London, United Kingdom), M. Bridgett (London, United Kingdom), Y. Ong (London, United Kingdom)
| |
Hospital re-admissions and deaths associated with COVID-19 illness: survival analysis
Z. Ali (Telford (Shropshire), United Kingdom), S. Ahmed (Telford (Shropshire), United Kingdom), A. Makan (Telford (Shropshire), United Kingdom), E. Crawford (Telford (Shropshire), United Kingdom), K. Srinivasan (Telford (Shropshire), United Kingdom), D. Dev (Telford (Shropshire), United Kingdom), N. Ahmad (Telford (Shropshire), United Kingdom), H. Moudgil (Telford (Shropshire), United Kingdom)
| |
SARS-CoV-2: Survival in COPD phenotypes
M. Pavitt (Billingshurst (West Sussex), United Kingdom), S. Krivinskas (Billingshurst (West Sussex), United Kingdom), J. Congleton (Billingshurst (West Sussex), United Kingdom), S. Hippolyte (Billingshurst (West Sussex), United Kingdom)
| |
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
C. Seebacher (Bolzano (BZ), Italy), G. Resch (Bolzano (BZ), Italy), E. Stirpe (Bolzano (BZ), Italy), R. Dongilli (Bolzano (BZ), Italy), L. Bonazza (Bolzano (BZ), Italy), P. Pernter (Bolzano (BZ), Italy), F. Ferro (Bolzano (BZ), Italy)
| |
Late Breaking Abstract - Post-trial follow-up after a randomized clinical trial of COVID-19 convalescent plasma.
M. Panighetti (Buenos Aires, Argentina), I. Esteban (Buenos Aires, Argentina), F. Polack (Buenos Aires, Argentina)
| |
Discussion
| |